Posts tagged Exelixis Inc.


Marshall Wace Pulled Back Holding in Intercept Pharmaceuticals Inc (ICPT), Optimistic About Valeant Pharmaceuticals Intl Inc (VRX) and Exelixis, Inc. (EXEL)

A first glance at this hedge fund’s strategic Q2 moves in biotech sector.

Read more

Exelixis, Inc. (EXEL) Focuses on CABOMETYX’s Label Expansion

Exelixis, Inc. (NASDAQ:EXEL) announced this morning that it has completed the submission of a supplemental …

Read more

Dynavax Technologies Corporation (DVAX) Has the Market Buzzing with Heplisav Approval at the Finish Line, Exelixis, Inc. (EXEL) Refractory RCC Drug Going Strong in its Launch

Dynavax’s Advantage Weighs Towards Heplisav’s Benefits Dynavax Technologies Corporation (NASDAQ:DVAX) shares are racing 5% today …

Read more

William Blair Bullish on Biotech: Sarepta Therapeutics Inc (SRPT), Dynavax Technologies Corporation (DVAX), and Exelixis, Inc. (EXEL)

Sarepta’s $12+ Million 2Q Beat Sarepta Therapeutics Inc (NASDAQ:SRPT) Duchenne muscular dystrophy (DMD) drug Exondys …

Read more

Biotech Beat: Arena Pharmaceuticals, Inc. (ARNA) and Exelixis, Inc. (EXEL)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) investors have a smile on their faces Monday evening, after the …

Read more

Key Takeaways From William Blair’s Annual Growth Stock Conference: Gilead Sciences, Inc. (GILD), Exelixis, Inc. (EXEL)

William Blair analyst John Sonnier is out highlighting standout insights from his 37th Annual Growth …

Read more

Oppenheimer Highlights Two Stocks to Avoid: Advanced Micro Devices, Inc. (AMD), Exelixis, Inc. (EXEL)

Earnings season always brings surprises and serves as a catalyst for companies. In light of …

Read more

Exelixis, Inc. (EXELׁ) Receives FDA Orphan Drug Designation for the Treatment of Hepatocellular Carcinoma

Exelixis, Inc. (NASDAQ:EXEL) announced that the FDA has granted orphan drug designation to cabozantinib for …

Read more

Analysts Speculate on Two Biotech Stocks: Valeant Pharmaceuticals Intl Inc (VRX), Exelixis, Inc. (EXEL)

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Exelixis, Inc. (NASDAQ:EXEL) have stirred up interest after Valeant …

Read more

Exelixis, Inc. (EXEL) Reports 4Q and Full Year 2016 Financial Results and Provides Business Update

Exelixis, Inc. (NASDAQ:EXEL) reported financial results for the fourth quarter and full year of 2016 …

Read more